STRO financials
Sutro Biopharma (STRO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- STRO revenue was $102.48M in fiscal 2025, net income -$191.09M.
STRO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $102.48M | – | -$158.37M | -$191.09M | -22.49 |
| 2024 | $62.04M | – | -$238.45M | -$227.46M | -29.40 |
| 2023 | $153.73M | – | -$89.28M | -$106.79M | -17.68 |
| 2022 | $67.77M | – | -$128.94M | -$119.20M | -23.34 |
| 2021 | $61.88M | – | -$98.52M | -$105.54M | -22.74 |
| 2020 | $42.72M | – | -$71.06M | -$32.13M | -9.83 |